Thrombocytosis as a Predictor of Distant Recurrence in Patients with Rectal Cancer

Archives of Medical Research

Volumn 43, Issue 4, 2012, Pages 305-311

  Cravioto Villanueva, Adrian ^a,b   Luna Perez, Pedro ^a   Gutierrez de la Barrera, Marco ^a   Martinez Gómez, Hector ^a   Maffuz, Antonio ^b   Rojas Garcia, Priscila ^b   Perez Alvarez, Claudia ^b   Rodriguez Ramirez, Saúl ^a   Rodriguez Antezana, Edgar ^a   Ramirez Ramirez, Lourdes ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b AMERICAN BRITISH COWDRAY MEDICAL CENTER   (Mexico)

Author keywords

Prognostic factor; Rectal cancer; Thrombocytosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONFIDENCE INTERVAL; DISTANT METASTASIS; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERITONEUM METASTASIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RECTUM CANCER; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOCYTOSIS; TWO TAILED TEST;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MEXICO; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOCYTOSIS; YOUNG ADULT;

EID: 84864095206     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.06.008     Document Type: Article

References (39)

1. Riess L. Zur pathologische Anaotmie des Blut. Arch Anat Cited in JAMA 1970, 211:1852-1853. Physiol Wissensch Med 1872;39:237-49.
2. Rodriguez G.C., Clarke P.D., Soper J.T., et al. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. Obstet Gynecol 1994, 83:445-448.
3. Hernández E., Donohue K.A., Anderson L.L., et al. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol 2000, 78:137-142.
4. Zeimet A.G., Marth C., Muller H.E., et al. Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1994, 170:549-554.
5. Gorelick C., Andikyan V., Mack M., et al. Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population. Int J Gynecol Cancer 2009, 19:1384-1389.
6. Ikeda M., Furukawa H., Imamura H., et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002, 9:287-291.
7. Symbas N.P., Townsend M.F., Keane T.E., et al. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int 2000, 86:203-207.
8. Shimada H., Oohira G., Okazumi S., et al. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 2004, 198:737-741.
9. Taucher S., Salat A., Gnant M., et al. Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 2003, 89:1098-1106.
10. Engans T., Hannisdal E. Blood analyses as prognostic factors in primary lung cancer. Acta Oncol 1990, 29:151-154.
11. Lidor Y.J., Xu F.J., Martinez M.O., et al. Production of constitutive macrophage colony-stimulating factor and interleukin-6 by human surface epithelial ovarian cells. Exp Cell Res 1993, 207:332-339.
12. Kabir S., Daar G.A. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma. Cancer Lett 1995, 95:207-212.
13. Wu C.W., Wang S.R., Chao M.F., et al. Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 1996, 91:1417-1422.
14. Nakazaki H. Preoperative and postoperative cytokines in patients with cancer. Cancer 1992, 70:709-713.
15. Karpatkin S., Pearlstein E. Role of platelets in tumor cell metastasis. Ann Intern Med 1981, 95:636-641.
16. Nieswandt B., Hafner M., Echtenacher B., et al. Lysis of tumour cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999, 59:1295-1300.
17. McCarty O.J., Mousa S.A., Bray P.F., et al. Immobilized platelets support human colon cell carcinoma tethering, rolling, and firm adhesion under dynamic flow conditions. Blood 2000, 96:1789-1797.
18. Burstein S.A., Harker L.A. Control of platelet production. Clin Haematol 1983, 12:3-22.
19. Metcalf D., Nicola N.A., Gearing D.P. Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. Blood 1990, 76:50-56.
20. Asano S., Okano A., Ozawa K., et al. In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 1990, 75:1602-1605.
21. Blay J.Y., Negrier S., Combaret V., et al. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 1992, 52:3317-3322.
22. Tsukamoto T., Kumamoto Y., Miyao N., et al. Interleukin-6 in renal cell carcinoma. J Urol 1992, 148:1778-1781.
23. Dosquet C., Schaetz A., Faucher C., et al. Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma. Eur J Cancer 1994, 30A:162-167.
24. Pinedo H.M., Verheul H.M., D'Amato R.J., et al. Involvement of platelets in tumour angiogenesis?. Lancet 1998, 352:1775-1777.
25. Kisucka J., Butterfield C.E., Duda D.G., et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci 2006, 103:855-860.
26. Tuszynski G.P., Gasic T.B., Rothman V.L., et al. Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res 1987, 47:4130-4133.
27. Thomas S.N., Zhu F., Schnaar R.L., et al. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem 2008, 283:15647-15655.
28. Verheul H.M., Pinedo H.M. Tumor growth: a putative role for platelets?. Oncologist 1998, 3:II.
29. Tuszynski G.P., Smith M., Rothman V.L., et al. Thrombospondin (TSP) levels in patients with malignancy. Thromb Haemost 1992, 67:607-611.
30. Kim Y.J., Borsig L., Varki N.M., et al. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci 1998, 95:9325-9330.
31. Gücer F., Moser F., Tamussino K., et al. Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol 1998, 70:210-214.
32. Verheul H.M., Hoekman K., Luykx-de Bakker S., et al. Platelet: transporter of vascular endothelial growth factor. Cancer Res Clin 1997, 3:2187-2190.
33. Poon R.T., Fan S., Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 2001, 19:1207-1225.
34. Dirix L.Y., Vermeulen P.B., Hubens G., et al. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol 1996, 7:843-848.
35. Guo P., Hu B., Gu W., et al. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 2003, 162:1083-1093.
36. Vinals F., Pouyssegur J. Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGFalpha signaling. Mol Cell Biol 2001, 21:7218-7230.
37. Werther K., Bülow S., Hesselfeldt P., et al. VEGF concentrations in tumour arteries and veins from patients with rectal cancer. APMIS 2002, 110:646-650.
38. Werther K., Christensen I.J., Nielsen H.J. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest 2002, 62:343-350.
39. Giralt J., Navalpotro B., Hermosilla E., et al. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy. Oncology 2006, 71:312-319.